Voyager Therapeutics, Inc.

Voyager Therapeutics, Inc.'s next confirmed earnings release is scheduled for November 10, 2026.

As of June 30, 2026, Voyager Therapeutics, Inc. has 61.27M shares outstanding.

As of June 30, 2026, Voyager Therapeutics, Inc. maintains a current ratio of 7.51, meaning it holds 7.5x the short-term assets needed to cover near-term liabilities.

Over the twelve months ended June 30, 2026, Voyager Therapeutics, Inc. posted a negative return on equity (ROE) of -54.09, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -41.45, reflecting losses generated across the asset base. The company generates approximately 4.05M in revenue per employee across its workforce of 148.75, a quick read on workforce productivity versus industry peers.

Over the twelve months ended June 30, 2026, Voyager Therapeutics, Inc. recorded 2.20M in income tax expense. The company reported a pretax loss of -1.88B and -1.88B in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

As of the close on July 13, 2026, Voyager Therapeutics, Inc.'s stock has gained approximately 1.61% over the past 52 weeks.

Over the twelve months ended June 30, 2026, Voyager Therapeutics, Inc. generated 602.05M in revenue and converted that into -1.88B in net income, yielding earnings per share of -31.56. EBITDA reached -1.98B, while operating income came in at -2.05B.

As of June 30, 2026, Voyager Therapeutics, Inc. holds 2.03B in cash and equivalents against 569.00M in total debt, resulting in a net debt position of -624.94M. Total book value stands at 2.70B, with working capital of 1.90B providing operational flexibility.

Voyager Therapeutics, Inc. produced -2.11B in operating cash flow over the twelve months ended June 30, 2026. After subtracting -14.80M in capital expenditures, free cash flow totaled -2.12B - equivalent to -35.69 per share.

These figures cover the twelve months ended June 30, 2026. The operating margin of -340.08 and net profit margin of -312.63 provide insight into operational efficiency.